BC

Birchview Capital Portfolio holdings

AUM $101M
1-Year Est. Return 34.62%
This Quarter Est. Return
1 Year Est. Return
+34.62%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$115M
AUM Growth
-$7.74M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
72
New
Increased
Reduced
Closed

Top Buys

1
+$728K
2
+$493K
3
+$476K
4
XENE icon
Xenon Pharmaceuticals
XENE
+$369K
5
PRTA icon
Prothena Corp
PRTA
+$351K

Top Sells

1
+$1.25M
2
+$914K
3
+$771K
4
MASI icon
Masimo
MASI
+$666K
5
AXGN icon
Axogen
AXGN
+$666K

Sector Composition

1 Healthcare 96.33%
2 Energy 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXDX
51
DELISTED
Accelerate Diagnostics
AXDX
$228K 0.2%
325,239
ARVN icon
52
Arvinas
ARVN
$699M
$211K 0.18%
30,000
+15,000
NPCE icon
53
Neuropace
NPCE
$344M
$202K 0.18%
16,442
+6,442
TELA icon
54
TELA Bio
TELA
$60.6M
$189K 0.16%
155,000
+30,000
KROS icon
55
Keros Therapeutics
KROS
$421M
$153K 0.13%
15,000
GOSS icon
56
Gossamer Bio
GOSS
$501M
$152K 0.13%
138,176
CGEM icon
57
Cullinan Oncology
CGEM
$464M
$151K 0.13%
20,000
LQDA icon
58
Liquidia Corp
LQDA
$1.94B
$148K 0.13%
10,013
+13
TECL icon
59
Direxion Daily Technology Bull 3x Shares
TECL
$4.17B
$144K 0.13%
20,000
+2,000
ATRA icon
60
Atara Biotherapeutics
ATRA
$104M
$131K 0.11%
22,000
ZBIO
61
Zenas BioPharma
ZBIO
$1.13B
$130K 0.11%
16,500
KPTI icon
62
Karyopharm Therapeutics
KPTI
$94.4M
$105K 0.09%
27,985
-4
TSVT
63
DELISTED
2seventy bio
TSVT
$76.6K 0.07%
15,500
-333
ALMS
64
Alumis Inc
ALMS
$467M
$61.4K 0.05%
10,000
IFRX icon
65
InflaRx
IFRX
$79.9M
$51K 0.04%
50,000
CMPX icon
66
Compass Therapeutics
CMPX
$731M
$45.6K 0.04%
+24,000
VTYX icon
67
Ventyx Biosciences
VTYX
$280M
$33.1K 0.03%
28,800
ZNTL icon
68
Zentalis Pharmaceuticals
ZNTL
$107M
$27K 0.02%
17,000
CHRS icon
69
Coherus Oncology
CHRS
$192M
– –
-82,000
SRPT icon
70
Sarepta Therapeutics
SRPT
$2.36B
– –
-3,500
CERO icon
71
CERo Therapeutics
CERO
$3.71M
– –
-6
BHVN
72
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-7,365
1 2
3